IL36A

IL36A

Target · IL-1 family cytokine

IL36A Interleukin 36 alpha · IL-1F6

IL36A (interleukin 36 alpha, also known as IL-1F6, FIL1E and IL1(epsilon)) is a pro-inflammatory cytokine of the IL-1 family. It signals through the IL-36 receptor to activate NF-kappa-B and MAPK pathways, mainly in epithelial barriers such as skin. Browse Assay Genie's current range of IL36A research reagents below, or read on for the biology behind the target.

Cytoplasmic and secretedIL-1 family cytokineRaised expression in psoriasis
158 aa
Protein length
~18 kDa
Molecular weight
2q14.1
Gene locus
IL-1 family</stat4_value> <parameter name="stat4_label">Protein family
Protein family
Target information

What is IL36A (interleukin 36 alpha)?

IL36A is a cytokine that binds to and signals through the IL1RL2/IL-36R receptor. Receptor engagement activates the NF-kappa-B and MAPK signalling pathways in target cells and drives a pro-inflammatory response. IL36A is part of the IL-36 signalling system, which is thought to operate in epithelial barriers and in local inflammatory responses. It resembles the IL-1 system and shares its coreceptor, IL1RAP.

The protein appears to be involved in skin inflammation, where it acts on keratinocytes, dendritic cells and, indirectly, T-cells to promote tissue infiltration, cell maturation and proliferation. In cultured keratinocytes it induces chemokines for macrophages, T-cells and neutrophils, including CCL3, CCL4, CCL5, CCL2, CCL17, CCL22, CCL20, CXCL8 and CXCL1. It also induces pro-inflammatory cytokines such as TNF, IL-8 and IL-6. In cultured monocytes it up-regulates IL-1 alpha, IL-1 beta and IL-6. In myeloid dendritic cells it raises surface CD83, CD86 and HLA-DR, and in monocyte-derived dendritic cells it supports maturation and T-cell proliferation. It may also contribute to pro-inflammatory effects in the lung.

The IL36A gene belongs to the interleukin 1 family and was formerly named interleukin 1 family, member 6 (epsilon). The IL36A protein is found in the cytoplasm and is secreted. NCBI Gene reports that it functions primarily in skin and shows increased expression in psoriasis. Decreased expression has been linked to a poor prognosis in hepatocellular carcinoma and colorectal cancer. The mouse ortholog is Il36a.

Skin inflammation

IL36A acts on keratinocytes, dendritic cells and indirectly on T-cells, and shows increased expression in psoriasis.

Epithelial barrier immunity

The IL-36 system is thought to be present in epithelial barriers and to take part in local inflammatory responses.

Cytokine and chemokine signalling

IL36A signalling through IL1RL2 and IL1RAP activates NF-kappa-B and MAPK and induces chemokines and cytokines such as TNF and IL-6.

Cancer prognosis research

Decreased IL36A expression has been linked to poor prognosis in hepatocellular carcinoma and colorectal cancer patients.

Background

IL36A frequently asked questions

What does IL36A do?

IL36A is a cytokine that binds the IL1RL2/IL-36R receptor and activates NF-kappa-B and MAPK signalling, producing a pro-inflammatory response. It seems to act on keratinocytes, dendritic cells and indirectly on T-cells in skin, and may have pro-inflammatory effects in the lung.

What other names does IL36A go by?

IL36A is also known as IL-1F6, IL1F6, FIL1, FIL1E, IL1(epsilon), MGC129552 and MGC129553. Its previous HGNC name was interleukin 1 family, member 6 (epsilon). The current name, interleukin 36 alpha, places it in the IL-1 family of interleukins.

Is IL36A linked to disease, and is it conserved in mouse?

NCBI Gene reports increased IL36A expression in psoriasis, and decreased expression linked to poor prognosis in hepatocellular carcinoma and colorectal cancer. A mouse ortholog, Il36a, exists. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other IL-1 family members, interleukins and inflammatory cytokines relevant to IL-36 signalling.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UHA7; product specifications from Assay Genie datasheets.

IL36A Product listing